ATYR
Price
$5.35
Change
+$0.13 (+2.49%)
Updated
Aug 6, 04:24 PM (EDT)
Capitalization
464.6M
7 days until earnings call
SLXN
Price
$8.30
Change
-$0.56 (-6.32%)
Updated
Aug 6, 04:51 PM (EDT)
Capitalization
5.13M
Interact to see
Advertisement

ATYR vs SLXN

Header iconATYR vs SLXN Comparison
Open Charts ATYR vs SLXNBanner chart's image
aTyr Pharma
Price$5.35
Change+$0.13 (+2.49%)
Volume$2.08K
Capitalization464.6M
Silexion Therapeutics
Price$8.30
Change-$0.56 (-6.32%)
Volume$200
Capitalization5.13M
ATYR vs SLXN Comparison Chart in %
Loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. SLXN commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Hold and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (ATYR: $5.22 vs. SLXN: $8.86)
Brand notoriety: ATYR and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 72% vs. SLXN: 38%
Market capitalization -- ATYR: $464.6M vs. SLXN: $5.13M
ATYR [@Biotechnology] is valued at $464.6M. SLXN’s [@Biotechnology] market capitalization is $5.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 1 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATYR and SLXN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 3 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • ATYR’s TA Score: 3 bullish, 6 bearish.
  • SLXN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than ATYR.

Price Growth

ATYR (@Biotechnology) experienced а -0.48% price change this week, while SLXN (@Biotechnology) price change was -28.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.86%. For the same industry, the average monthly price growth was +14.59%, and the average quarterly price growth was +13.46%.

Reported Earning Dates

ATYR is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATYR($465M) has a higher market cap than SLXN($5.13M). ATYR YTD gains are higher at: 44.199 vs. SLXN (-70.614). SLXN has higher annual earnings (EBITDA): -16.96M vs. ATYR (-65.9M). SLXN has less debt than ATYR: SLXN (3.48M) vs ATYR (13M). ATYR (0) and SLXN (0) have equivalent revenues.
ATYRSLXNATYR / SLXN
Capitalization465M5.13M9,057%
EBITDA-65.9M-16.96M389%
Gain YTD44.199-70.614-63%
P/E RatioN/AN/A-
Revenue00-
Total Cash76.3MN/A-
Total Debt13M3.48M373%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATYRSLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
8%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
20%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
31%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
42%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 10 days ago
51%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
44%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ORCX37.500.88
+2.40%
Defiance Daily Target 2X Long ORCL ETF
TBFC27.200.23
+0.84%
The Brinsmere Fund - Conservative ETF
FFLV22.140.04
+0.18%
Fidelity Fundamental Large Cap Value ETF
HERD40.440.06
+0.14%
Pacer Cash Cows Fund of Funds ETF
QUS162.64-1.05
-0.64%
SPDR® MSCI USA StrategicFactors ETF

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
+3.98%
MGTX - ATYR
41%
Loosely correlated
-1.28%
RZLT - ATYR
41%
Loosely correlated
-0.68%
AMLX - ATYR
41%
Loosely correlated
+2.76%
SLDB - ATYR
41%
Loosely correlated
-1.76%
IDYA - ATYR
40%
Loosely correlated
-3.52%
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-1.99%
IMA - SLXN
59%
Loosely correlated
-0.66%
CELC - SLXN
50%
Loosely correlated
-0.67%
MRSN - SLXN
43%
Loosely correlated
+2.62%
CHRS - SLXN
26%
Poorly correlated
+4.86%
QSI - SLXN
25%
Poorly correlated
N/A
More